Study of lung disease causes in primary ciliary dyskinesia
Part of Ear, nose & throat, Genetic & congenital, Heart & circulation, Lungs & breathing clinical trials.
This study looks at how primary ciliary dyskinesia (PCD—a lifelong problem with tiny lung “sweepers”) affects the lungs. You may be able to join if you strongly seem to have PCD based on symptoms, or if you’re a healthy person with a close family member who has confirmed PCD.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have symptoms that make doctors strongly suspect you have PCD
- OR you are a healthy volunteer with a family member who has confirmed PCD
- No need to have PCD confirmed already if your symptoms strongly suggest it
- If you are not related to someone with confirmed PCD, this trial may not fit you
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a registry that collects information from people diagnosed with primary ciliary dyskinesia. It may help researchers better understand the condition over time and improve future care.
This study follows people with primary ciliary dyskinesia (PCD) and looks at their regular ear, nose, and throat (ENT) checkups over time. Your participation may help doctors better understand how ENT care should be followed in PCD.
This study tests an inhaled medication (hypertonic saline) to see if it helps clear mucus from the lungs of people with Primary Ciliary Dyskinesia (PCD). It involves exercise testing and regular lung function checks.
This study looks at how the airways in people with primary ciliary dyskinesia (PCD) react to certain triggers. It aims to understand if these airways are more sensitive, which could help improve treatment for breathing problems.
This study (RaDiCo-DCP) follows people who have a confirmed diagnosis of primary ciliary dyskinesia, a condition that can affect how your lungs clear mucus. The trial looks at long-term symptoms over time, which may help improve care planning and understanding of the condition.
This study invites people who have been told they may have, or who have confirmed, primary ciliary dyskinesia. It aims to better understand living with PCD and what helps people day to day.
Hear when a new Kartagener Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.